SELENBP1 and neoplasm: However, we observed that Thbs1-knockdown MTO showed no significant difference in growth and metastatic formation in the splenic injection model (Supplementary Fig. 4b–g), suggesting no obvious contribution of tumor epithelium-derived THBS1 to tumor progression.